Comprehensive profiling of 8p11-12 amplification in breast cancer

被引:186
作者
Gelsi-Boyer, W
Orsetti, B
Cervera, N
Finetti, P
Sircoulomb, F
Rougé, C
Lasorsa, L
Letessier, A
Ginestier, C
Monville, F
Esteyriès, S
Adélaïde, J
Esterni, B
Henry, C
Ethier, SP
Bibeau, F
Mozziconacci, MJ
Charafe-Jauffret, E
Jacquemier, J
Bertucci, F
Birnbaum, D
Theillet, C
Chaffanet, M
机构
[1] Inst Natl Sante & Rech Med, UMR 599, Dept Mol Oncol, Marseilles Canc Inst, Marseille, France
[2] CRLC Val Aurelle Paul Lamarque, Dept Pathol, Montpellier, France
[3] Ctr Hosp Univ Rennes, Lab Cytogenet, Rennes, France
[4] Karmanos Inst, Detroit, MI USA
关键词
D O I
10.1158/1541-7786.MCR-05-0128
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
In human carcinomas, especially breast cancer, chromosome arm 8p is frequently involved in complex chromosomal rearrangements that combine amplification at 8p11-12, break in the 8p12-21 region, and loss of 8p21-ter. Several studies have identified putative oncogenes in the 8p11-12 amplicon. However, discrepancies and the lack of knowledge on the structure of this amplification lead us to think that the actual identity of the oncogenes is not definitively established. We present here a comprehensive study combining genomic, expression, and chromosome break analyses of the 8p11-12 region in breast cell lines and primary breast tumors. We show the existence of four amplicons at 8p11-12 using array comparative genomic hybridization. Gene expression analysis of 123 samples using DNA microarrays identified 14 genes significantly overexpressed in relation to amplification. Using fluorescence in situ hybridization analysis on tissue microarrays, we show the existence of a cluster of breakpoints spanning a region just telomeric to and associated with the amplification. Finally, we show that 8p11-12 amplification has a pejorative effect on survival in breast cancer.
引用
收藏
页码:655 / 667
页数:13
相关论文
共 61 条
[1]
Adams J, 2005, CANCER RES, V65, P66
[2]
A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRGI gene [J].
Adélaïde, J ;
Huang, HE ;
Murati, A ;
Alsop, AE ;
Orsetti, A ;
Mozziconacci, MJ ;
Popovici, C ;
Ginestier, C ;
Letessier, A ;
Basset, C ;
Courtay-Cahen, C ;
Jacquemier, J ;
Theillet, C ;
Birnbaum, D ;
Edwards, PAW ;
Chaffanet, M .
GENES CHROMOSOMES & CANCER, 2003, 37 (04) :333-345
[3]
Adelaide J, 1998, GENE CHROMOSOME CANC, V22, P186, DOI 10.1002/(SICI)1098-2264(199807)22:3<186::AID-GCC4>3.0.CO
[4]
2-S
[5]
Adeyinka A, 2000, INT J MOL MED, V5, P235
[6]
Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers [J].
Armes, JE ;
Hammet, F ;
de Silva, M ;
Ciciulla, J ;
Ramus, SJ ;
Soo, WK ;
Mahoney, A ;
Yarovaya, N ;
Henderson, MA ;
Gish, K ;
Hutchins, AM ;
Price, GR ;
Venter, DJ .
ONCOGENE, 2004, 23 (33) :5697-5702
[7]
Bernardino L, 1998, GENE CHROMOSOME CANC, V23, P100, DOI 10.1002/(SICI)1098-2264(199810)23:2<100::AID-GCC2>3.0.CO
[8]
2-6
[9]
Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy [J].
Bertucci, F ;
Finetti, P ;
Rougemont, J ;
Charafe-Jauffret, E ;
Nasser, V ;
Loriod, W ;
Camerlo, J ;
Tagett, R ;
Tarpin, C ;
Houvenaeghel, G ;
Nguyen, C ;
Maraninchi, D ;
Jacquemier, J ;
Houlgatte, R ;
Birnbaum, D ;
Viens, P .
CANCER RESEARCH, 2004, 64 (23) :8558-8565
[10]
The translocation t(8;l6)(p11, p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB binding protein [J].
Borrow, J ;
Stanton, VP ;
Andresen, JM ;
Becher, R ;
Behm, FG ;
Chaganti, RSK ;
Civin, CI ;
Disteche, C ;
Dube, I ;
Frischauf, AM ;
Horsman, D ;
Mitelman, F ;
Volinia, S ;
Watmore, AE ;
Housman, DE .
NATURE GENETICS, 1996, 14 (01) :33-41